LINC00102

Across TCGA pan-cancer cohorts, LINC00102 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC00102 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC00102 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00102 expression acts as an unfavorable survival marker, although some lineages such as SKCM and BRCA show a favorable association.

UVM, UCS, and KICH are the cancer types where LINC00102 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	III,IV	0.107	0.677	.004	51	view →
UCS	OS	Median	III,IV	0.342	0.705	.006	48	view →
KICH	OS	Tertile	All	0.800	0.954	.024	18	view →
SKCM	OS	Median	IV	0.724	0.267	.005	15	view →
BRCA	DFS	Quartile	III,IV	0.739	0.407	.002	14	view →
BLCA	DFS	Median	III,IV	0.645	0.499	.013	12	view →
STAD	DFS	Median	III,IV	0.491	0.656	.018	10	view →
LGG	OS	Median	All	0.309	0.551	.008	8	view →
ESCA	DFS	Quartile	II,III,IV	0.255	1.000	.006	7	view →
MESO	OS	Median	II,III,IV	0.476	0.618	.018	7	view →
TGCT	DFS	Median	All	0.779	0.588	.024	6	view →
ACC	OS	Tertile	III,IV	1.000	0.495	.041	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC00102–UVM (DFS)

Open the UVM breakdown →